266 related articles for article (PubMed ID: 34385691)
1. Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.
Nagata T; Dwyer CA; Yoshida-Tanaka K; Ihara K; Ohyagi M; Kaburagi H; Miyata H; Ebihara S; Yoshioka K; Ishii T; Miyata K; Miyata K; Powers B; Igari T; Yamamoto S; Arimura N; Hirabayashi H; Uchihara T; Hara RI; Wada T; Bennett CF; Seth PP; Rigo F; Yokota T
Nat Biotechnol; 2021 Dec; 39(12):1529-1536. PubMed ID: 34385691
[TBL] [Abstract][Full Text] [Related]
2. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
Monine M; Norris D; Wang Y; Nestorov I
J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
[TBL] [Abstract][Full Text] [Related]
3. A single-cell map of antisense oligonucleotide activity in the brain.
Mortberg MA; Gentile JE; Nadaf NM; Vanderburg C; Simmons S; Dubinsky D; Slamin A; Maldonado S; Petersen CL; Jones N; Kordasiewicz HB; Zhao HT; Vallabh SM; Minikel EV
Nucleic Acids Res; 2023 Aug; 51(14):7109-7124. PubMed ID: 37188501
[TBL] [Abstract][Full Text] [Related]
4. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
Hara RI; Yoshioka K; Yokota T
Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.
Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS
J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489
[TBL] [Abstract][Full Text] [Related]
6. Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides.
Dastpeyman M; Sharifi R; Amin A; Karas JA; Cuic B; Pan Y; Nicolazzo JA; Turner BJ; Shabanpoor F
Int J Pharm; 2021 Apr; 599():120398. PubMed ID: 33640427
[TBL] [Abstract][Full Text] [Related]
7. Direct intraventricular delivery of drugs to the rodent central nervous system.
DeVos SL; Miller TM
J Vis Exp; 2013 May; (75):e50326. PubMed ID: 23712122
[TBL] [Abstract][Full Text] [Related]
8. Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides.
Nishi R; Ohyagi M; Nagata T; Mabuchi Y; Yokota T
Mol Ther; 2022 Jun; 30(6):2210-2223. PubMed ID: 35189344
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Model Analysis and Simulation of Pharmacokinetics and
Goto A; Yamamoto S; Igari T; Matsumoto SI; Chisaki I; Iida K; Nakayama M; Oda A; Kakoi Y; Uchida A; Miyata K; Nishikawa M; Nagata T; Kusuhara H; Yokota T; Hirabayashi H
J Pharmacol Exp Ther; 2023 Jan; 384(1):197-204. PubMed ID: 36273821
[TBL] [Abstract][Full Text] [Related]
10. Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisks.
Aly AE; Caron NS; Black HF; Schmidt ME; Anderson C; Ko S; Baddeley HJE; Anderson L; Casal LL; Rahavi RSM; Martin DDO; Hayden MR
J Control Release; 2023 Aug; 360():913-927. PubMed ID: 37468110
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides selectively suppress target RNA in nociceptive neurons of the pain system and can ameliorate mechanical pain.
Mohan A; Fitzsimmons B; Zhao HT; Jiang Y; Mazur C; Swayze EE; Kordasiewicz HB
Pain; 2018 Jan; 159(1):139-149. PubMed ID: 28976422
[TBL] [Abstract][Full Text] [Related]
12. Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS.
Wahlestedt C; Khorkova O
Cell Mol Neurobiol; 2021 Jul; 41(5):849-853. PubMed ID: 32656646
[TBL] [Abstract][Full Text] [Related]
13. The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration.
Jafar-Nejad P; Powers B; Soriano A; Zhao H; Norris DA; Matson J; DeBrosse-Serra B; Watson J; Narayanan P; Chun SJ; Mazur C; Kordasiewicz H; Swayze EE; Rigo F
Nucleic Acids Res; 2021 Jan; 49(2):657-673. PubMed ID: 33367834
[TBL] [Abstract][Full Text] [Related]
14. Systemic Brain Delivery of Antisense Oligonucleotides across the Blood-Brain Barrier with a Glucose-Coated Polymeric Nanocarrier.
Min HS; Kim HJ; Naito M; Ogura S; Toh K; Hayashi K; Kim BS; Fukushima S; Anraku Y; Miyata K; Kataoka K
Angew Chem Int Ed Engl; 2020 May; 59(21):8173-8180. PubMed ID: 31995252
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System.
Kennedy Z; Gilbert JW; Godinho BMDC
Methods Mol Biol; 2022; 2434():345-353. PubMed ID: 35213030
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides on neurobehavior, respiratory, and cardiovascular function, and hERG channel current studies.
Kim TW; Kim KS; Seo JW; Park SY; Henry SP
J Pharmacol Toxicol Methods; 2014; 69(1):49-60. PubMed ID: 24211663
[TBL] [Abstract][Full Text] [Related]
17. DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo.
Ohyagi M; Nagata T; Ihara K; Yoshida-Tanaka K; Nishi R; Miyata H; Abe A; Mabuchi Y; Akazawa C; Yokota T
Nat Commun; 2021 Dec; 12(1):7344. PubMed ID: 34937876
[TBL] [Abstract][Full Text] [Related]
18. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860
[TBL] [Abstract][Full Text] [Related]
19. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.
D'Souza A; Nozohouri S; Bleier BS; Amiji MM
Pharm Res; 2023 Jan; 40(1):77-105. PubMed ID: 36380168
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modeling for hepatic delivery and efficacy of antisense oligonucleotides with lipophilic ligands in mice.
Watanabe A; Katsube T
Biopharm Drug Dispos; 2021 Apr; 42(4):178-187. PubMed ID: 33724506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
